Skip to main content
TipRanks
Go Ultimate75% OFF
SciTech Development Inc logo

SciTech Development Inc: Valuation, Funding & Investors

SciTech Development Inc. is a clinical-stage pharmaceutical company focused on pioneering advanced cancer treatments through its proprietary nanotechnology drug-delivery platform. The company is currently conducting clinical trials for its lead drug candidate, ST-001 nanoFenretinide™, which has shown promising results in treating T-cell Non-Hodgkin Lymphoma. With its innovative approach, SciTech aims to provide more effective and accessible treatment options across a broad range of cancers.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$6M
Total Funding Rounds
1
Latest Funding Amount
$6M
Latest Funding Round
Convertible Notes

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 24, 2025Convertible Notes$5.50M―

Similar Companies

A snapshot of private companies similar to SciTech Development Inc, helping you discover and navigate related company profiles.

Related News and Analysis